Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank67
5Y CAGR-63.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-63.1%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 0.09% |
| 2023 | 7.27% |
| 2022 | -48.26% |
| 2021 | -327.31% |
| 2020 | 76.55% |
| 2019 | 13.17% |
| 2018 | -32.04% |
| 2017 | -32.16% |
| 2016 | -89.85% |
| 2015 | 0.00% |